| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.054 | 0.3 |